Suven Life gets patents from Norway, South Korea, Singapore
The granted claims pertain to new chemical entities (NCEs) developed by the firm to treat disorders associated with neurodegenerative diseases.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Brain | Chemistry | Neurology | Norway Health | Singapore Health | South Korea Health